Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03527290 · ClinicalTrials.gov registry record · NA

Dietary Approaches for Cardiometabolic Health

A NA study, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT03527290: Completed NA study, sponsored by University of California, Irvine.

NCT03527290 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03527290, a NA study, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This pilot study aims to recruit 30 adults with abdominal obesity, without major chronic disease, and test whether clinical dietary advice that is solely focused on the timing of eating (time restricted eating), has an effect on cardiometabolic health compared to standard dietary advice for cardiometabolic health, which is focused on content. The goal of this pilot study is to develop and hone dietary counseling approaches for time restricted eating for RD's in a clinical practice paradigm, and collect data on testing this intervention compared to standard dietary counseling approaches for cardiometabolic health.

Primary Outcome

Ratio of fasting triglycerides to HDL cholesterol

Interventions

  • BEHAVIORAL Time Restricted Eating
  • BEHAVIORAL Standard Cardiometabolic Health Diet

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-01-15
Est. Completion 2020-11-05
Phase NA
University of California, Irvine

368 total trials

What the finished NCT03527290 record still lists

NCT03527290 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Time Restricted Eating is the first listed.

NCT03527290 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03527290 about?

NCT03527290 is a clinical study titled "Dietary Approaches for Cardiometabolic Health". This pilot study aims to recruit 30 adults with abdominal obesity, without major chronic disease, and test whether clinical dietary advice that is solely focused on the timing of eating (time restricted eating), has an effect on cardiometabolic health compared to standard dietary advice for cardiome...

What is the current status of trial NCT03527290?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-01-15. Estimated completion is 2020-11-05.

What interventions are being tested in trial NCT03527290?

The interventions under investigation include: Time Restricted Eating (BEHAVIORAL), Standard Cardiometabolic Health Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT03527290?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03527290's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03527290, the US trial registry maintained by the National Library of Medicine. NCT03527290 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.